A detailed history of Bennett Selby Investments LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Bennett Selby Investments LP holds 26,151 shares of NVO stock, worth $2.66 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
26,151
Previous 23,537 11.11%
Holding current value
$2.66 Million
Previous $3.36 Million 7.32%
% of portfolio
1.31%
Previous 1.51%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$119.07 - $145.42 $311,248 - $380,127
2,614 Added 11.11%
26,151 $3.11 Million
Q2 2024

Jul 10, 2024

BUY
$122.71 - $146.91 $129,336 - $154,843
1,054 Added 4.69%
23,537 $3.36 Million
Q1 2024

Apr 11, 2024

BUY
$102.11 - $135.92 $47,787 - $63,610
468 Added 2.13%
22,483 $2.89 Million
Q4 2023

Jan 08, 2024

BUY
$87.78 - $105.45 $147,119 - $176,734
1,676 Added 8.24%
22,015 $2.28 Million
Q3 2023

Oct 16, 2023

SELL
$90.94 - $199.54 $1.27 Million - $2.78 Million
-13,947 Reduced 68.57%
6,392 $581,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $954,506 - $2.09 Million
10,496 Added 106.63%
20,339 $1.85 Million
Q2 2023

Jul 18, 2023

BUY
$155.98 - $172.65 $166,898 - $184,735
1,070 Added 12.2%
9,843 $1.59 Million
Q1 2023

May 08, 2023

BUY
$132.34 - $159.14 $302,661 - $363,953
2,287 Added 35.26%
8,773 $1.4 Million
Q4 2022

Jan 18, 2023

BUY
$102.55 - $135.33 $9,639 - $12,721
94 Added 1.47%
6,486 $878,000
Q3 2022

Oct 11, 2022

BUY
$95.28 - $116.93 $218,191 - $267,769
2,290 Added 55.83%
6,392 $637,000
Q2 2022

Aug 04, 2022

SELL
$103.24 - $121.81 $13,214 - $15,591
-128 Reduced 3.03%
4,102 $457,000
Q1 2022

Apr 11, 2022

BUY
$93.1 - $112.54 $32,491 - $39,276
349 Added 8.99%
4,230 $470,000
Q4 2021

Jan 19, 2022

SELL
$95.88 - $117.08 $9,971 - $12,176
-104 Reduced 2.61%
3,881 $435,000
Q3 2021

Oct 08, 2021

BUY
$84.42 - $106.62 $336,413 - $424,880
3,985 New
3,985 $383,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bennett Selby Investments LP Portfolio

Follow Bennett Selby Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennett Selby Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Bennett Selby Investments LP with notifications on news.